RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Choroidal Neovascularization
Accession: DOID:9001044
browse the term
Definition: A pathological process consisting of the formation of new blood vessels in the CHOROID.
Synonyms: exact_synonym: Choroid Neovascularization; Choroid Neovascularizations; Choroidal Neovascularizations
primary_id: MESH:D020256 ; RDO:0007376
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:16689928 PMID:17466298 PMID:22633972
RGD:2289282 RGD:8694464 RGD:8695931
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
BMP4
bone morphogenetic protein 4
ISO
RGD
PMID:21411747 PMID:22392094
RGD:8699493 RGD:8699501
NCBI chr 1:183,415,989...183,422,888
Ensembl chr 1:183,416,146...183,422,637
G
C5
complement C5
ISO
RGD
PMID:16849499
RGD:7411733
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
G
CCL2
chemokine (C-C motif) ligand 2
treatment
ISO
RGD
PMID:17389519
RGD:8548832
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:22205983
RGD:8657364
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CCR2
C-C motif chemokine receptor 2
ISO
associated with Macular Degeneration
RGD
PMID:19525930
RGD:6893454
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
G
CFB
complement factor B
ISO
RGD
PMID:16849499
RGD:7411733
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
G
CFH
complement factor H
treatment
ISO
associated with myopia;DNA:SNP: :rs1061170(human) DNA:SNPs:cds:p.Y402H,I62V(human)
RGD
PMID:22536038 PMID:22678500 PMID:23258212
RGD:7364943 RGD:7365030 RGD:7365031
G
DLL4
delta like canonical Notch ligand 4
treatment
ISO
RGD
PMID:21063852
RGD:12859045
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
F7
coagulation factor VII
ISO
mouse protein in a rat model
RGD
PMID:19357351
RGD:2312299
NCBI chr11:78,512,389...78,518,668
Ensembl chr11:78,512,137...78,518,668
G
FGF2
fibroblast growth factor 2
treatment
ISO
RGD
PMID:10359334
RGD:8655568
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
G
FLT1
fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:10849558 PMID:23804076 PMID:23977149
RGD:10402112 RGD:10402113 RGD:10402115
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
GLI1
GLI family zinc finger 1
treatment
ISO
RGD
PMID:21063852
RGD:12859045
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
HGF
hepatocyte growth factor
ISO
protein:increased expression:choroidal tissue:
RGD
PMID:19013152
RGD:8548599
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:21063852
RGD:12859045
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HTRA1
HtrA serine peptidase 1
no_association
ISO
associated with Myopia; DNA:snp:promoter:g.-625G>A (rs11200638) (human) human gene in mouse model
RGD
PMID:18682806 PMID:19680273 PMID:21844367
RGD:7394694 RGD:7394720 RGD:7394749
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
ICAM1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:retina, choroid, sclera (rat)
RGD
PMID:20497436
RGD:4145405
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IGF1R
insulin like growth factor 1 receptor
treatment
ISO
RGD
PMID:19032681
RGD:10045869
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:24489934
RGD:10045942
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:16903779 PMID:22802947
RGD:7364853 RGD:7365068
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL2
interleukin 2
treatment
ISO
associated with Macular Degeneration;protein:decreased expression:aqueous humor:
RGD
PMID:19262441
RGD:10047086
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
ITGAV
integrin subunit alpha V
ISO
RGD
PMID:15287373
RGD:1582458
NCBI chr15:91,604,666...91,711,843
Ensembl chr15:91,604,676...91,711,851
G
JAM3
junctional adhesion molecule 3
treatment
ISO
RGD
PMID:22323465
RGD:7488935
NCBI chr 9:60,629,245...60,738,979
Ensembl chr 9:60,613,400...60,738,924
G
KDR
kinase insert domain receptor
treatment
ISO
RGD
PMID:12937991 PMID:15249365 PMID:18436847 PMID:19085383 PMID:22997228
RGD:8549713 RGD:8549716 RGD:8549738 RGD:8549741 RGD:8549747
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
LEP
leptin
ISO
associated with Metabolic Syndrome X;mRNA:increased expression:retina (rat)
RGD
PMID:25380250
RGD:10053625
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LOC110256000
membrane primary amine oxidase-like
ISO
RGD
PMID:18436961
RGD:2313908
NCBI chr12:19,996,324...20,007,006
G
LOXL1
lysyl oxidase like 1
ISO
RGD
PMID:18296663
RGD:7394725
NCBI chr 7:59,481,410...59,505,161
Ensembl chr 7:59,481,412...59,505,149
G
MMP13
matrix metallopeptidase 13
ISO
RGD
PMID:20700625
RGD:10043118
NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:21666238 PMID:25314292
RGD:13207327 RGD:8657062
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
treatment
ISO
protein:increased expression:plasma
RGD
PMID:12368198 PMID:17304258 PMID:25314292
RGD:13207327 RGD:8547840 RGD:8657061
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
PTCH1
patched 1
ISO
mRNA,protein:increased expression:choroid:
RGD
PMID:21063852
RGD:12859045
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
SERPINF1
serpin family F member 1
treatment
ISO
human protein in a rat model protein:increased expression:aqueous humor (human) human gene in a mouse model
RGD
PMID:11424092 PMID:12037010 PMID:15312607 PMID:16490490 PMID:19778186 PMID:19850839 More...
RGD:2312356 RGD:27226711 RGD:28867245 RGD:8554866 RGD:8554883 RGD:8655557
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
SOD1
superoxide dismutase 1
ISO
RGD
PMID:16844785
RGD:1581207
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
STAT3
signal transducer and activator of transcription 3
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:17525280 PMID:23094067
RGD:10403057 RGD:8694307
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
TLR2
toll like receptor 2
ISO
associated with Chlamydophila Infections;
RGD
PMID:20393111
RGD:8552825
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TYR
tyrosinase
ISO
ClinVar Annotator: match by term: Choroidal neovascularization
ClinVar
PMID:666627 PMID:1429711 PMID:1820207 PMID:7704033 PMID:7955413 PMID:9158138 PMID:10766867 PMID:17952075 PMID:18326704 PMID:18488027 PMID:18488028 PMID:18925668 PMID:19208379 PMID:19533789 PMID:20301345 PMID:21541274 PMID:23504663 PMID:25216246 PMID:25741868 PMID:28378818 PMID:28492532 PMID:28976636 PMID:30472657 PMID:31077556 PMID:35803923 More...
NCBI chr 9:22,517,047...22,604,290
Ensembl chr 9:22,517,047...22,604,290
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:choroidal tissue,retina:
CTD RGD
PMID:16680105 PMID:16723717 PMID:19013152 PMID:20237252
RGD:7483614 RGD:8548459 RGD:8548599
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VEGFB
vascular endothelial growth factor B
ISO
RGD
PMID:19369214
RGD:2314323
NCBI chr 2:7,872,873...7,876,149
Ensembl chr 2:7,872,870...7,876,118
G
DLL4
delta like canonical Notch ligand 4
treatment
ISO
RGD
PMID:21526177
RGD:155663484
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
SERPINE1
serpin family E member 1
treatment severity
ISO
human gene in mouse model mRNA:increased expression:retina (mouse)
RGD
PMID:11292663 PMID:12766088 PMID:26610445
RGD:11073722 RGD:8547735 RGD:8547737
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SMO
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:21063852
RGD:12859045
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
C2
complement C2
susceptibility
ISO
DNA:SNP:intron:c.1360+62G>T (rs547154) (human)
RGD
PMID:22232432
RGD:7411694
NCBI chr 7:24,020,590...24,034,042
Ensembl chr 7:23,995,982...24,033,930
G
CFB
complement factor B
susceptibility
ISO
DNA:snp:intron:c.1169-69T>C (rs541862) (human)
RGD
PMID:22232432
RGD:7411694
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
G
CFH
complement factor H
no_association susceptibility
ISO
DNA:missense mutation:cds:p.Y402H (rs1061170) (human) DNA:SNP, missense mutation:promoter, cds:g.-257C>T, p.I62V (rs3753394, rs800292) (human)
RGD
PMID:18515590
RGD:7411726
G
CRP
C-reactive protein, pentraxin-related
ISO
RGD
PMID:17400294
RGD:9491775
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
ELN
elastin
no_association susceptibility
ISO
DNA:SNP: :rs2301995(human) DNA:SNP,haplotype: :rs2301995(human)
RGD
PMID:18326737 PMID:21391811
RGD:9585729 RGD:9585730
NCBI chr 3:11,214,194...11,245,891
Ensembl chr 3:11,214,205...11,244,897
G
HTRA1
HtrA serine peptidase 1
susceptibility
ISO
human gene in mouse model DNA:snp:promoter:g.-625G>A (rs11200638) (human)
RGD
PMID:21844367 PMID:23326481
RGD:7394749 RGD:7394751
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:serum
RGD
PMID:23559867
RGD:8547885
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:serum
RGD
PMID:23559867
RGD:8547885
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
VEGFA
vascular endothelial growth factor A
susceptibility
ISO
DNA:SNP,haplotype: :rs833069(human)
RGD
PMID:22307775
RGD:7483605
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all